|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:1246-1254
© 2000 The American Association for Thoracic Surgery
CARDIOPULMONARY SUPPORT AND PHYSIOLOGY |
From the Departments of Surgery and Biomedical Engineering, Duke University Medical Center, Durham, NC.
Supported by National Institutes of Health grants HL08902, HL09315, and HL29436 and by Specialized Center of Research (SCOR) grant HL17670.
Address for reprints: Donald D. Glower, MD, Box 3851, Duke University Medical Center, Durham, NC 27710 (E-mail: glowe001{at}mc.duke.edu ).
Introduction: Calcitonin gene-related peptide, a potent vasodilating inotropic agent, increases coronary artery perfusion when administered exogenously and reduces ischemic injury in nonmyocardial tissue. However, it is unclear whether this agent improves recovery of myocardial performance after reversible myocardial ischemia.
Methods: Nine dogs underwent complete occlusion of the left anterior descending coronary artery for 15 minutes and were monitored during 24 hours of reperfusion. Calcitonin generelated peptide (0.07 µg · kg1 · min1), nitroglycerin (65 µg · kg1 · min1), or saline solution placebo was infused intravenously during initial reperfusion. Ischemia/reperfusion was repeated in concurrent 24-hour periods until all animals received infusions in random order. Micromanometry and sonomicrometry determined left ventricular pressure and myocardial segment length. Myocardial performance, based on the linear relationship between stroke work and end-diastolic segment length, was estimated with the preload recruitable work area.Results were analyzed as percent control and compared statistically with the use of repeated measures analysis of variance.
Results: Recovery of myocardial performance was augmented during reperfusion with calcitonin generelated peptide infusion relative to placebo (P = .005; mean preload recruitable work area ± SE after calcitonin generelated peptide infusion, 2484 ± 705 mm Hg at 90 minutes of reperfusion versus 1473 ± 300 mm Hg for placebo. Recovery of performance after nitroglycerin infusion was similar to recovery after placebo.
Conclusions: Calcitonin generelated peptide infusion improves recovery of contractile function in stunned myocardium. Unlike inotropic agents that impair recovery from reversible ischemia, calcitonin generelated peptide may confer cardioprotective effects on ischemic myocardium.
This article has been cited by other articles:
![]() |
R. Huang, A. Karve, I. Shah, M. C. Bowers, D. J. DiPette, S. C. Supowit, and G. S. Abela Deletion of the mouse {alpha}-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1291 - H1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |